The vaccine FluMist, manufactured by MedImmune, which was acquired by AstraZeneca in 2007, was first approved by the FDA in 2003 for individuals between five and 49 years of age. Its approval has ...
The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the ...
No doctor? No problem. In a first, the US Food and Drug Administration on Friday approved a nasal spray flu vaccine for ...
GlobalData on MSN1d
Thermo Fisher expands its presence with a new lab in SwedenThermo Fisher Scientific, headquartered in Massachusetts, announced that it will open a new bioanalytical laboratory in GoCo Health Innovation City, located in Gothenburg, Sweden. The new building, ...
Instead of four equal quarterly distributions, AstraZeneca insists on two payments per year, with a greater portion announced ...
Ella Robertson McKay managing director of One Young World envisions a future where ethical leadership shapes global ...
In early UK corporate news, AstraZeneca reported a US drug approval, while Legal & General announced it has struck a deal to sell its housebuilding arm. Here is what you need to know at the London ...
Meet the Management at ESMO 2024 Conference September 16, 2024 2:00 PM ETCompany ParticipantsPascal Soriot - Chief ...
In 2022, despite harsh covid-19 lockdowns, 25 new foreign R&D centres opened in Shanghai. Last year, when overall foreign ...
A Warrington engineering group supporting energy transition, has completed a two-year project to transform a redundant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback